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Genetic analysis of a large Indian family with an autosomal dominant cataract phenotype allowed us to identify a novel
cataract gene, CRYBA4. After a genomewide screen, linkage analysis identiﬁed a maximum LOD score of 3.20 (recom-
bination fraction [v] 0.001) with marker D22S1167 of the b-crystallin gene cluster on chromosome 22. To date, CRYBA4
was the only gene in this cluster not associated with either human or murine cataracts. A pathogenic mutation was
identiﬁed in exon 4 that segregated with the disease status. The c.317TrC sequence change is predicted to replace the
highly conserved hydrophobic amino acid phenylalanine94 with the hydrophilic amino acid serine. Modeling suggests
that this substitution would signiﬁcantly reduce the intrinsic stability of the crystalline monomer, which would impair
its ability to form the association modes critical for lens transparency. Considering that CRYBA4 associates with CRYBB2
and that the latter protein has been implicated in microphthalmia, mutational analysis of CRYBA4 was performed in
32 patients affected with microphthalmia (small eye). We identiﬁed a c.242TrC (Leu69Pro) sequence change in exon 4
in one patient, which is predicted here to disrupt the b-sheet structure in CRYBA4. Protein folding would consequently
be impaired, most probably leading to a structure with reduced stability in the mutant. This is the ﬁrst report linking
mutations in CRYBA4 to cataractogenesis and microphthalmia.
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Cataracts are a leading cause of blindness worldwide, af-
fecting all societies. A signiﬁcant proportion of cases are
genetically determined.1 More than 15 genes for cataracts
have been identiﬁed, of which the crystallin genes are the
most commonly mutated.2 Most of the crystallins have
been associated with either murine or human cataracts.
Crystallins function primarily as structural proteins of the
vertebrate lens, accounting for 80%–90% of the soluble
protein fraction. In the human lens, a-crystallin consti-
tutes 40% of the crystallins, b-crystallin 35%, and g-crys-
tallin 25%.3 The structural stability of crystallins is im-
portant to lens transparency, since they last a lifetimewith
virtually no protein turnover.1,4
We studied a previously described, four-generation In-
dian family (family C1325) affected with autosomal dom-
inant congenital lamellar cataract. The pathogenic role of
the g-crystallin genes and that of GJA8 were previously
excluded by sequence analysis of the coding sequence.5
Thirteen affected individuals were examined and available
for this study. DNA from unaffected individuals and
spouses were also available (ﬁg. 1). These unaffected in-
dividuals were not all examined and were therefore coded
as “unknown” for further genetic analysis. Informed con-
sent was obtained in accordance with the Tenets of the
Declaration of Helsinki. Most affected individuals were
diagnosed during childhood. However, affected individ-
uals III:2 (late 30s) and III:22 (43 years old) (ﬁg. 1) remain
unoperated. This suggests an early insult with variable
expressivity.
A genomewide linkage scan used 388 microsatellite
markers (average resolution 10 cM). Pedigree structurewas
conﬁrmed using PREST analysis.6,7 Two-point linkage anal-
ysis was performed under the assumption of autosomal
dominant inheritance with complete penetrance and a
disease-allele frequency of 0.001 (MLINK program of the
Linkage software package, version 2). A candidate locus
was identiﬁed on chromosome 22 where amaximumpair-
wise LOD score of 3.20 at recombination fraction (v) 0.001
was obtained with D22S1167 (table 1). Location score
analysis, performed by use of LINKMAP v5.1, supported
the strong evidence for linkage to this region (maximum
location score [log10] 3.50, with the interval and ﬂanking
markers D22S351 to D22S1167). Fine mapping of the dis-
ease interval used STRP markers available through public
databases. Direct sequencing of the coding sequence of
the four genes of the chromosome 22 crystallin gene clus-
ter (CRYBB2, CRYBB3, CRYBB1, and CRYBA4) identiﬁed a
heterozygous TrC transition in CRYBA4 (MIM *123631)
exon 4. Mutation of the highly conserved Phe 94
(c.317TrC [NCBI accession number NM_001886])
Figure 1. Family C132 pedigree, with haplotypes. Affected individuals (blackened symbols) with a haplotype were clinically examined. “Unaffected” individuals (unblackened
symbols) were not examined. Individuals III:18 and IV:13 deﬁned the upper boundary of the disease interval and excluded CRYBB2 (exons 1–3) and CRYBB3 as candidate genes. A
lower boundary for the disease interval was not identiﬁed. The affected haplotype is depicted in red.
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Table 1. Two-Point Linkage Results Between the Cataract Phenotype and Markers
on Chromosome 22
Markera
IMDb
(cM)
LOD at v p
Zmax vmax.0 .01 .05 .1 .2 .3 .4
GATA198E* … 2.93 1.50 .47 .08 .16 .16 .09 .17 .246
D22S446* 12.6 .55 1.06 1.45 1.47 1.22 .82 .38 1.48 .081
D22S1174 4.9 .27 .78 1.19 1.24 1.03 .69 .31 1.24 .088
CRYB2-CA 2.1 .10 .01 .19 .29 .33 .27 .16 .33 .182
D22S351 1.9 2.63 2.58 2.38 2.12 1.58 .99 .41 2.63 .001
D22S1167* 1.4 3.20 3.14 2.90 2.59 1.91 1.19 .48 3.20 .001
D22S1144 2.7 2.90 2.85 2.62 2.33 1.71 1.05 .40 2.90 .001
D22S685* 4.9 .75 .74 .67 .59 .43 .28 .13 .75 .001
D22S445* 13.4 1.83 1.79 1.62 1.41 .97 .54 .19 1.83 .001
D22S444* 5.7 .46 .45 .41 .36 .27 .17 .09 .46 .001
NOTE.—Individuals presumed “unaffected” were coded as “unknown” for linkage analysis. Boldface
type denotes denotes the marker with maximum LOD score (D22S1167).
a An asterisk (*) denotes markers genotyped in the initial genome scan.
b IMD p intermarker distance, from the Marshﬁeld map.
Figure 2. Comparative sequence analysis of CRYBA4. Red, pathogenic amino acid change; yellow, change of uncertain pathogenicity.
changes the large, hydrophobic, nonpolar amino acid
phenylalanine to the small, polar amino acid serine. By
use of haplotype analysis and NciI restriction-enzyme di-
gestion, the change was shown to segregate with the dis-
ease phenotype. Two individuals who were not available
for examination carried the affected haplotype (ﬁg. 1). Of
these, case IV:15 was reported not to be eligible for a driv-
ing license in Kuwait. The Phe94Sermutationwas not seen
in 239 control individuals (160 of mixed ethnicity, 53 In-
dian, and 26 Pakistani) nor in 50 patients affected with
congenital cataracts and 50 patients affected with
age-related cataract (data not shown, total of 678
chromosomes).
Multiple sequence alignments generated using
ClustalW showed that the Phe at position 94 is highly
conserved in mouse, rat, bovine, zebraﬁsh, and chicken
(ﬁg. 2). In the absence of a known three-dimensional
structure for the CRYBA4 protein, homology modeling
techniques were used to gain insight into the possible role
of Phe94 in maintaining the native protein state. The par-
tial sequence from amino acid 12 to amino acid 98 of
CRYBA4 was extracted from the RefSeq resource of the
National Center for Biotechnology Information (NCBI)
(accession number NP_001877) and was used to search
the Protein Databank (PDB)8,9 for a suitable template from
among the known crystallin structures. The selected tem-
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Figure 3. Homology modeling of CRYBA4. A, Modeled structure of CRYBA4. Depicted is the N-terminal domain of the predicted atomic
structure of CRYBA4, built using the known structure of 1oki_A as template (see text). The protein backbone is drawn using a solid
ribbon model. a-Helix, b-strand, and turn structures are colored in red, cyan, and light green, respectively. Val36, Leu69, and Phe94
residues are shown in full atomic detail. B, Environment of the Phe94 and Ser94 side chains in the modeled CRYBA4 three-dimensional
structure. The side chains of Phe94 and Ser94 are colored in blue and orange, respectively. Residues whose atoms are !6.0 A˚ from the
side-chain atoms of Phe94 are shown. The ∼100-A˚3 cavity formed by replacing the bulky Phe 94 with Ser is outlined by the mesh
colored in cyan. This cavity is lined by the side chains of hydrophobic residues surrounding Ser94. The cavity volume was computed
using the ProShape software, with a probe radius of 0.2 A˚, which approximates the cavity delimited by the molecular surface of the
surrounding residues. C, Portion of the CRYBA4 structure in the vicinity of residue 69, highlighting the differences in the b-sheet
backbone structures of the wild-type (Leu69) and mutant (Pro69) proteins. The backbone nitrogen of Leu69 forms a hydrogen bond
with the carbonyl group of Trp54, contributing to the stability of the antiparallel b-sheet structure. This hydrogen bond cannot form
in the Pro69 mutant. Its backbone nitrogen cannot act as a hydrogen-bond donor, since it is covalently linked to the proline ring.
plate was crystallin-b B1 (CRYBB1) (PDB entry 1oki_A),
which displayed 47% sequence identity with the partial
CRYBA4 query sequence. The CRYBA4 sequence was
aligned to the template protein by use of Needleman-
Wunsch alignment.10 Gaps in the CRYBA4 corresponding
to a-helices and b-strands in the template structure were
manually displaced toward positions in loop regions. The
main-chain atoms in the CRYBA4 were assigned the spa-
tial coordinates of the equivalent residues in the CRYBB1
template. The conformations of the side-chains were built
onto the CRYBA4 model backbone by a Metropolis Monte
Carlo procedure implemented in the software Modzinger.
Insertions and deletions in loop regions were modeled by
searching a database of fragments from known protein
structures deposited in the PDB for those that are com-
patible with the target sequence and the template scaf-
fold,11 followed by a structure reﬁnement procedure. The
Phe94Ser structure was generated by replacing the Phe side
chain with that of Ser at position 94 and optimizing the
Ser side chain while keeping all surrounding side chains
and backbone atoms ﬁxed at their position in the native
CRYBA4 model. (The atomic coordinates of the models
built for the wild-type and all mutant proteins analyzed
in this study are available at the Web site of the Centre
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Figure 4. Sequence logo representation (WebLogo) of the con-
servation pattern at speciﬁc residue positions in CRYBA4. The logo
represents the position-speciﬁc information content (conservation
level), in bits, of the multiple sequence alignments computed using
BLAST CRYBA4 sequences. The indicated residue positions follow
the numberings of the CRYBA4 sequence. The total height of each
column is proportional to the information content (conservation)
of the corresponding position, and the height of a letter in a
column (representing a given amino acid, using the one-letter
code) is proportional to its frequency at that position.33,34
Table 2. CRYBA4 Novel Sequence Variants
Sequence
Change/
Positiona
Protein
Effect
No. of Individuals (MAFb)
Screening
Methodology
Patients with
Microphthalmia
Healthy
Controls
c.142 GrA Val36Met 1/32 (.02) 4/160 (.01) NlaIII
IVS3-87, CrT 2/32 (.03) 11/56 (.10) ARMSc assay
IVS3-36, CrT 2/32 (.03) 18/118 (.08) FokI
c.242TrC Leu69Pro 1/32 (.02) 0/184 (.0) MspI
c.317TrCd Phe94Ser 0/32 0/239 (.0) NciI
IVS43e, ArG 2/32 (.03) 20/90 (.1) ARMS assay
IVS5-18, GrA 2/32 (.03) 9/119 (.04) SSCP/AccI
a Nucleotide changes are numbered according to NM_001886 (mRNA) or with
respect to CRYBA4 intron position on UCSC genome browser May 2004: chr22:
25,342,481-5,351,186.
b MAF p minor-allele frequency (all heterozygote sequence changes).
c ARMS p ampliﬁcation refractory mutation system.
d Family C132 mutation.
e This mutation does not signiﬁcantly change the splice-site score (79.0 wild
type, 75.7 mutant), calculated by use of Alex Dong Li’s Splice Site Score
Calculator.
for Computational Biology at the Hospital for Sick Chil-
dren in Toronto.) Inspection of the CRYBA4model reveals
that Phe94 is positioned in the hydrophobic core formed
between the two beta sheets of the second Greek keymotif
not far from the connecting peptide (amino acids 98–103),
as illustrated in ﬁgure 3A and 3B. Replacing Phe with Ser
in this position introduced a polar group into the hydro-
phobic core of the protein and created a large packing
defect, or cavity, in this region, with a volume, computed
by the Prove software, of ∼100 A˚3.12 Each of these effects
is expected to destabilize the native CRYBA4 structure. On
the basis of measures of transfer of free energy of amino
acid side chains from organic solvent to water,13 replace-
ment of a completely buried Phe side chain by a Ser would
destabilize the native state of the CRYBA4 protein by∼2.5–
2.8 kcal/mol, with the lower value representing the case
in which the Ser g OH would form hydrogen bonds with
the backbone of neighboring residues, as is often observed
in proteins containing completely buried Ser side chains.14
If we use estimates by Eriksson et al.15 and Xu et al.16—
made on the basis of mutagenesis, calorimetric, and struc-
tural studies of T4-phage lysozyme mutants—formation
of the ∼100 A˚3 cavity on the PherSer replacement at po-
sition 94 would add as many as 2.2 kcal/mol of destabi-
lization free energy (22 cal/A˚3 of cavity volume). This
would bring the total destabilization free energy due to
the Phe94Ser mutation in CRYBA4 to close to 4.7–5 kcal/
mol. This would represent a sizable loss of stability for the
protein, considering that the unfolding free energy of
wild-type crystallin monomers is probably !10 kcal/mol
(a value of 8.7 kcal/mol was reported for bB2 crystallin17),
which could well preclude its proper folding, which is
required to form the higher-order associations with other
crystalline proteins that are critical for the formation and
maintenance of lens transparency.
We also noted that, of the eight amino acid residues in
contact with Phe94, all are hydrophobic and four are
highly conserved in crystalline sequences (Trp12, Cys33,
Trp54, and Leu91), with the remaining four partially con-
served but always replaced by other hydrophobic residues
(ﬁg. 4). This is an additional indication that packing of
hydrophobic side chains in this region is important for
stability.
The role of CRYBA4 in eye development was also as-
sessed, because of previous documentation of homozy-
gous changes in CRYBB2 that were associated with severe
microphthalmia (small eye) and cataract18 and the inter-
action of CRYBB2-CRYBA4 monomers.19 In addition, we
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Figure 5. Expression proﬁle of CRYBA4 in eye tissues. Lanes 1–7 represent adult eye tissues: 1, sclera; 2, cornea; 3, iris; 4, ciliary
body; 5, lens; 6, choroid; 7, retina. Lanes 8–11 are from newborn eye tissues: 8, cornea; 9, lens; 10, choroids; 11, retina. Lane 12 is
RT-minus. Lane 13 is no-template control (no cDNA template in the PCR). M, molecular size marker. A duplex PCR was performed on
cDNA obtained from different tissues by use of ampliﬁcation of GAPDH transcript as control for the quality and quantity of RT-PCR
templates. Upper band (A) represents the 640-bp PCR product of ampliﬁcation with CRYBA4-speciﬁc primers, exon 2–6 (ampliﬁed only
in lens tissues), whereas the lower band (B) is the result of ampliﬁcation with GAPDH-speciﬁc primers. Numbers on the left show
fragment size in base pairs. Samples 1–7 and 8–11 were ampliﬁed at the same time with the same concentration of GAPDH. PCR products
were electrophoresed on 2% agarose gels stained with ethidium bromide.
reported a mutation in CRYBB1 associated with a micro-
cornea cataract phenotype.20 Mutational analysis of 32 pa-
tients affected with bilateral microphthalmia, performed
using a combination of single-strand conformation poly-
morphism analysis (SSCP) and direct sequencing, identi-
ﬁed several novel sequence changes in the CRYBA4 in-
tron and coding sequence (table 2). The heterozygous
c.242TrC transition (Leu69Pro) seen in exon 4 is pre-
dicted to be pathogenic. The index case was given a di-
agnosis of bilateralmicrophthalmia and cataractswith sec-
ondary enophthalmia (sinking of the eyes). No family
member was available for clinical assessment. There was
no family history of any eye anomaly, suggesting that this
change is a de novo mutation. Leu69Pro is highly con-
served between species (ﬁg. 2) and is not seen in 368 chro-
mosomes from healthy control individuals. Protein-struc-
ture modeling predicts that the change of Leu69 to Pro,
in the middle of the b-sheet (ﬁg. 3A and 3C), would likely
break the b-sheet. The mutant structure would be very
unstable and would not fold appropriately. A 142GrA
(Val36Met) sequence change observed in exon 4 was also
present in 4 of 320 chromosomes from healthy control
individuals (minor-allele frequency 1%). Although this
change also involves a highly conserved amino acid, struc-
ture modeling suggested that themutant protein structure
maintains a stable conformation with predicted normal
folding (ﬁg. 3A). A number of other novel intronic se-
quence changes were discovered (table 2) and are pre-
sumed to be nonpathogenic, because of their presence in
healthy controls.
PCR of cDNA (generated by RT-PCR, with random hex-
amer primers) from various human tissues (eyes obtained
from the local Eye Bank; other tissue RNA fromStratagene)
showed that the expression of CRYBA4 is speciﬁc to the
lens and appears to be higher in the neonatal lens. No
expression was detected in retina, cornea, iris, choroid,
sclera, or ciliary body (ﬁg. 5). Recent work also suggested
that the expression was mostly in lens ﬁber cells gener-
ating the high refractive index and transparency required
for lens function.21
The b-crystallins are major constituents of the mam-
malian lens, where they associate into dimers, tetramers,
and higher oligomers. Appropriate association of crystal-
lins into higher-order complexes is critical to the main-
tenance of lens transparency.22 The b-crystallin family
contains three basic (CRYBB) and four acidic (CRYBA) pro-
tein chains, believed to derive from a common ancestor.23
CRYBA4 encodes a predicted 196-aa protein. The con-
served human CRYBA4 crystallin domain is 92%–94%
identical to rat and bovine bA4. Lampi et al. found that
there are 11 major soluble proteins in the young human
lens and that bA4 constitutes ∼5% of the total.24
The ability of the normal lens cells to regulate and dif-
ferentiate proteins in the correct conformation through-
out development might rely directly on the ability of ac-
curately translated lens proteins to interact in their
properly folded three-dimensional conformation. The
temporal expression of crystallin genes vary in develop-
ment. Different CRYB proteins are found in both prenatal
and postnatal developing lens, and their interactionswith
each other, as well as with other lens proteins, are im-
portant in maintenance of lens transparency.25,26 From rat
studies, it was shown that the expression ofCryba4 ismax-
imal 2–8 mo after birth, whereas the expression of Crybb2
increases until 6 mo after birth, and the transcript is pre-
sent in remarkable amounts even 1 year after birth.27 We
have shown a higher expression level of CRYBA4 in hu-
man neonatal lens versus adult (ﬁg. 5).
Documented varieties of mouse cataract mutants either
arose spontaneously or were recovered after parental treat-
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ment by chemical mutagen or radiation. However, there
is currently no mouse phenotype identiﬁed for Cryba4
(Mouse Genome Informatics). To date, the mutations
identiﬁed in the b-crystallin genes cluster always involved
exon 6.5,20,28–32
The present work is, to our knowledge, the ﬁrst dem-
onstration for the role of CRYBA4 in cataractogenesis and
microphthalmia and also the ﬁrst to show involvement
of a highly conserved area of CRYB exon 4. The early ex-
pression of CRYBA4 and the predicted protein destabili-
zation by the mutations presented here may explain the
early onset of the phenotypes described.
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